Miniatura

Fitxers

846504.pdf (351.81 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2024-03-10

Llicència de publicació

cc-by-nc-nd (c) Sociedad Española de Cardiología, 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/225582

Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.rec.2023.11.005

Resum

The new guidelines of the European Society of Cardiology (ESC) 2023 for the management of patients with cardiovascular (CV) disease (CVD) and diabetes incorporate a central figure that focuses on the presentation of a patient with diabetes and CVD: first case: a patient with CVD that includes atherosclerotic cardiovascular disease (ASCVD), atrial fibrillation (AF) and heart failure (HF), in whom diabetes screening must be performed; second case, a patient with diabetes in whom CVD or chronic kidney disease (CKD) must be ruled out. In the first case, there are no changes for the diagnosis of diabetes using the already known diagnostic criteria1: a) fasting plasma glucose ≥ 126mg/dL; b) glycated hemoglobin (HbA1c) ≥ 6.5%; c) plasma glucose 2hours after an oral glucose overload test (75g) ≥ 200mg/dL; and d) plasma glucose ≥ 200mg/dL in patients with classic symptoms of hyperglycemia or a hyperglycemic crisis. In the second case, CVD screening is recommended based on the patient's symptoms and electrocardiogram (ECG). The document does not introduce peptides in this screening, or imaging tests, or detection of ischemia in asymptomatic patients with diabetes.

Matèries

Cardiologia, Diabetis, Malalties cardiovasculars

Matèries (anglès)

Cardiology, Diabetes, Cardiovascular diseases

Citació

Col·leccions

Articles publicats en revistes (Infermeria Fonamental i Clínica)

Citació

CAMPUZANO, Raquel, MAZÓN, Pilar, CASTRO CONDE, Almudena, CID ÁLVAREZ, Ana belén, CRUZADO ÁLVAREZ, Concepción, DÍEZ VILLANUEVA, Pablo, FERNÁNDEZ OLMO, Rosa, FREIXA PAMIAS, Román, MARZAL MARTIN, Domingo, MIRABET PÉREZ, Sonia, FERREIRO, José luis, AVANZAS, Pablo, ANDREA, Rut, BORAITA, Araceli, CALVO, David, CAMPUZANO RUIZ, Raquel, DELGADO, Victoria, DOS SUBIRÁ, Laura, GÓMEZ-DOBLAS, Juan josé, MARTÍNEZ MOMBLÁN, Ma. antonia, MAZÓN, Pilar, PASCUAL FIGA, Domingo, SANCHIS, Juan, DE LA TORRE HERNÁNDEZ, José maría, VIVAS, David. Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes. _Revista Española de Cardiología (English Edition)_. 2024. Vol. 77, núm. 3, pàgs. 196-200. [consulta: 23 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/225582]

Exportar metadades

JSON - METS

Compartir registre